Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | 5'-nucleotidase NT5E |
Clinical data | |
Other names | MEDI9447 |
ATC code |
|
Identifiers | |
CAS Number |
|
ChemSpider |
|
UNII |
|
KEGG |
|
Chemical and physical data | |
Formula | C6348H9826N1710O1998S40 |
Molar mass | 143350.81 g·mol−1 |
Oleclumab (INN;[1] development code MEDI9447) is a human monoclonal antibody targeting the ectonucleotidase CD73 that was designed for the treatment of pancreatic and colorectal and other cancers.[2]
This drug was developed by MedImmune/AstraZeneca.[3]